Baxter International (BAX)Gendell Jeffrey L added to its stake +191K shares

1.76M

Shares reported · +191K vs prior quarter

0.33%

Disclosed portfolio weight

$37.4M

Reported value

Holdings as of

Jun 30, 2026

Filed

Aug 14, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Jul 29, 2026Company filing · Form 8-K · Results, Other newsReported its results, and reported other company news
2. Jul 31, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On July 31, 2026, Anita Zielinski notified Baxter International Inc. (the “Company”) of her decision to resign as the Company’s Interim Chief Financial Officer and Senior Vice President, Chief Accounting Officer and Controller, effective as of September 15, 2026, to join another company.”
3. Aug 6, 2026FDAFDA drug approval: Levetiracetam
4. Aug 6, 2026FDARecall: Clindamycin Injection USP in 5% Dextrose, 900 mg per 50 mL (12 mg/mL) in GALAXY 50 mL Single Dose Container, Rx only, Sterile Nonpyrogenic, Baxter Healthcare C…
5. Aug 6, 2026FDARecall: Vasopressin, in 0.9% Sodium Chloride Injection, 20 units per 100 mL (0.2 units/mL), 100mL Single-Dose Container, Rx only, Sterile, Baxter Healthcare Corporatio…
6. Aug 6, 2026FDARecall: Daptomycin, in 0.9% Sodium Chloride Injection, 1,000 mg per 100 mL (10 mg/mL), 1,000 mg total, in 1000 mL Single Dose Container, Rx only, Sterile Nonpyrogenic,…
7. Aug 11, 2026FDARecall: Baxter Novum IQ Syringe Pump, Model Number 40800BAXUS
8. Aug 11, 2026FDARecall: Baxter Novum IQ Syringe Pump, Loaner, Model Number 40800BAXUSL
9. Aug 13, 2026FDAFDA device clearance: Dashboard (P007000)
10. Aug 14, 2026FDAFDA drug approval: Sodium Bicarbonate

What came next

1. Aug 17, 2026FDARecall: 0.9% Sodium Chloride Injection USP 500 mL, VIAFLEX Plastic Containers, with 24 units per case. Baxter Healthcare Corporation, Deerfield, IL, 60015, USA, Made i…
2. Aug 17, 2026FDARecall: Dextrose Injection, USP, 70 %, 2000 mL bags, Rx Only, Baxter Healthcare Corporation Deerfield, IL, 60016, Made in USA, NDC 00338-0719-06
3. Aug 18, 2026Company filing · Form 8-K · Material agreement, Other newsSigned an important agreement, and reported other company news
4. Aug 18, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On August 18, 2026, Baxter International Inc. (the “Company”) appointed John Rogers as Executive Vice President and Chief Financial Officer (“CFO”), effective as of October 1, 2026 (the “Transition Date”).”
5. Aug 18, 2026FDARecall: PRO+ 40" MRS SURFACE, mattress with Advanced Microclimate Technology (AMT) uses a non-powered system of intake and output valves to provide weight-based pressu…
6. Aug 18, 2026FDARecall: PRO+ MRS SURFACE FOR VERSACARE, mattress with Advanced Microclimate Technology (AMT) uses a non-powered system of intake and output valves to provide weight-ba…
7. Aug 18, 2026FDARecall: PRO+ 36" MRS SURFACE, mattress with Advanced Microclimate Technology (AMT) uses a non-powered system of intake and output valves to provide weight-based pressu…
8. Sep 11, 2026FDAFDA drug approval: Metoclopramide Hydrochloride
9. Sep 18, 2026FDAFDA drug approval: Rocuronium Bromide

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Baxter International

For Baxter International, OQRO holds 8 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BAX page.

How this filing works

• SEC Form 13F

Other disclosures at Baxter International

• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 13, 2026
• SEC Form 13F-HRAug 11, 2026
• SEC Form 13F-HRAug 10, 2026
• SEC Form 13F-HRAug 7, 2026

Everything OQRO holds on this company is on its BAX page.